URINARY AND SERUM BENZODIAZEPINE DETERMINATIONS AND ITS CORRELATION WITH THE SEDATION WAKENING IN CRITICAL CARE PATIENTS by S Rosich Andreu et al.
POSTER PRESENTATION Open Access
Urinary and serum benzodiazepine
determinations and its correlation with the
sedation wakening in critical care patients
S Rosich Andreu1*, G Moreno Muñoz1, J Marin Corral1, E Machado1, R Sanchez2, À Vilanova2, M Olono3,
MA Bodí1,4,5, AH Rodríguez1,4,5, A Sandiumenge Camps6
From ESICM LIVES 2015
Berlin, Germany. 3-7 October 2015
Introduction
The accumulation of benzodiazepines (BZD) or their
metabolites in critically ill patients may prolong wakening
times after its discontinuation increasing their morbidity
and leading to the overuse of complementary testing to
assess neurological function. Route urine/serum determi-
nation of BZD are used in some centers to determine BZD
clearance, however the correlation of BZD urine/blood
concentration and its clinical action has not been deter-
mined in critically ill patients.
Objectives
We aimed to investigate the correlation between the
presence of BZD in urine and blood (midazolam-MDZ)
with the time of wakening after discontinuation of pro-
longed intravenous (iv) infusion of MDZ in critical care
patients. We also aimed to determine the impact of
renal failure (ARF) in the efficacy of those test.
Methods
Prospective, observational study in a 30-bed adult medi-
cal-surgical intensive care unit (ICU) from Oct 2014 to
Apr 2015. All patients admitted with GCS>8 who were
sedated with iv MDZ infusion >72 hours were followed
from sedation discontinuation until complete wakening.
Patients with chronic use of BZD previous to ICU
admission or treated with oral BZD after MDZ iv dis-
continuation were excluded. Daily urine qualitative (One
step rapid test, Healgen®’) and blood quantitative (Advia
Chemistry, Siemens®) BZD determinations were taken
until the first negative urine BZD result. Renal function
was determined using RIFLE scale. Time to wake up
was defined as the number of hours from BZD disconti-
nuation to the ability to obey simple commands.
Results
A total of 32 patients were included, 8 of whom were
excluded due to chronic use of BZD (2[25%]) or treat-
ment with oral BZD after MDZ iv discontinuation
(6[75%]). The remaining 24 patients (male 70%, 63.3(SD
12) years old, APACHE II 23(SD 8), SAPS 3 40(SD 22)
were sedated with 2382.32mg (SD 3402.20) of MDZ
during 7(SD 6) days.A strong correlation between MDZ
serum levels and urine BZD positivity (p < 0.0001,R²
0.89) was found. We also found an statistically signifi-
cant correlation between the number of days of positive
BZD urinary determinations and the time to wake up
(p = 0.002), but with a low clinical relevance (R² 0.392).
Discrimination power (ROC) of MDZ serum levels to
predict the wakening showed an AUC of 0.71 (0.61-0.80,
p = 0.001).Patients with ARF (14 [58%]) had more days
of positive BZD urinary determinations compared with
the group without ARF (10[41%])(10.5[SD 7.8]vs.4.6[SD
4.9],p = 0.032), despite receiving lower total doses of
MDZ (2245.72mg [SD 2589.88] vs. 2573.57mg [SD
4452.21],p = 0.838) respectively.
Conclusions
Qualitative BZD urine determination is not a useful tool
to predict wake up times in critically ill patients receiving
prolonged MDZ infusions. The determination of serum
levels of midazolam can readily predict the wakening
time in more than 70% of ICU patients who had received
long-term MDZ sedation.
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